Patents by Inventor Franz Werner

Franz Werner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8348555
    Abstract: The present invention relates to a shuttering element for limiting a section of a trench wall. The shuttering element is characterized by a plurality of shuttering parts which have a plate-shaped base body, consisting of concrete in particular, and are connected to one another at their adjoining horizontal front faces. Furthermore, the invention relates to a shuttering part as well as a method for producing a trench wall in the ground.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: January 8, 2013
    Assignee: Bauer Maschinen GmbH
    Inventors: Erwin Emil Stoetzer, Franz Werner Gerressen, Roland Wenger
  • Publication number: 20110091379
    Abstract: The invention relates to a medicament against tumors and their metastases, which preferentially settle in bone tissue, comprising active ingredient at least one binding molecule that binds to bone sialoprotein or a fragment thereof in serum or plasma.
    Type: Application
    Filed: October 8, 2010
    Publication date: April 21, 2011
    Applicant: ARMBRUSTER BIOTECHNOLOGY GMBH
    Inventors: Franz Paul ARMBRUSTER, Markus Karmatschek, Franz Werner Nader, Ulf Joerg Forssmann, Mats Paulsson, Martin R. Berger
  • Patent number: 7825219
    Abstract: The invention relates to a medicament against tumors and their metastases, which preferentially settle in bone tissue, comprising as active ingredient at least one binding molecule which binds to bone sialoprotein or a fragment thereof in serum or plasma.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: November 2, 2010
    Assignee: Armbruster Biotechnology GmbH
    Inventors: Franz Paul Armbruster, Markus Karmatschek, Franz Werner Nader, Ulf Joerg Forssmann, Mats Paulsson, Martin R. Berger
  • Publication number: 20090104182
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering front such conditions and to methods of screening compounds for their ability to enhance TNF ? biosynthesis.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Inventors: Franz-Werner KLUXEN, Bernd HENTSCH, Thomas EHRING, Marian BRANDLE, Jorg HOHEISEL, Marcus FROHME, Dimitri ZUBAKOV
  • Publication number: 20080265126
    Abstract: The present invention relates to a shuttering element for limiting a section of a trench wall. The shuttering element is characterized by a plurality of shuttering parts which have a plate-shaped base body, consisting of concrete in particular, and are connected to one another at their adjoining horizontal front faces. Furthermore, the invention relates to a shuttering part as well as a method for producing a trench wall in the ground.
    Type: Application
    Filed: April 3, 2008
    Publication date: October 30, 2008
    Inventors: Erwin Emil Stoetzer, Franz Werner Gerressen, Roland Wenger
  • Publication number: 20070293579
    Abstract: The present invention relates to the novel finding that inhibition of human CARP protein or of CARP DNA/mRNA may successfully cure heart disorders, especially heart failure in humans. The invention relates, therefore, to pharmaceutical compositions containing substances, preferably of lower molecular weight, which may influence the activity of cardiac CARP. The invention relates, furthermore, to a method of treatment heart failure using CARP inhibitory compounds, to methods for screening these inhibitors and to the use of CARP as diagnostic tool.
    Type: Application
    Filed: February 20, 2007
    Publication date: December 20, 2007
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Claudia Wilm, Marian Braendle, Thomas Ehring, Thomas Eschenghagen, Oliver Zolk
  • Publication number: 20060154244
    Abstract: HNHLA17 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HNHLA17 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: July 6, 2001
    Publication date: July 13, 2006
    Inventor: Franz-Werner Kluxen
  • Publication number: 20050084860
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering from such conditions and to methods of screening compounds for their ability to enhance TNF ? biosysthesis.
    Type: Application
    Filed: November 30, 2002
    Publication date: April 21, 2005
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Thomas Ehring, Marian Brandle, Jorg Hoheisel, Marcus Frohme, Dimitri Zubakov
  • Publication number: 20050058647
    Abstract: This invention relates to newly identified polypeptides and polynucleotides encoding such polypeptides sometimes hereinafter referred to as “novel phosphodiesterase type 7b (PDE7b)”, to their use in diagnostic and in identifying compounds that may be agonists, antagonists that are potentially useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: February 20, 2001
    Publication date: March 17, 2005
    Inventors: Franz-Werner Kluxen, Bernd Hentsch
  • Publication number: 20050054034
    Abstract: GPRFWK1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing GPRFWK1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: June 11, 2001
    Publication date: March 10, 2005
    Inventors: Franz-Werner Kluxen, Klaus Duecker
  • Patent number: 6787548
    Abstract: Thienopyrimidines of the formula I and their physiologically acceptable salts, in which R1, R2 and X have the meanings indicated in claim 1, exhibit phosphodiesterase V inhibition and can be employed for the treatment of disorders of the cardiovascular system and for the treatment and/or therapy of potency disorders.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: September 7, 2004
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Rochus Jonas, Pierre Schelling, Franz-Werner Kluxen, Maria Christadler
  • Publication number: 20040106149
    Abstract: GPCR-HFRN63 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing GPCR-HFRN63 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: March 19, 2003
    Publication date: June 3, 2004
    Inventor: Franz-Werner Kluxen
  • Publication number: 20040073003
    Abstract: Neuromedin U delta polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing neuromedin U delta polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: April 9, 2003
    Publication date: April 15, 2004
    Inventor: Franz-Werner Kluxen
  • Publication number: 20040071695
    Abstract: LTDrec polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing LTDrec polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: August 8, 2003
    Publication date: April 15, 2004
    Inventors: Franz-Werner Kluxen, Klaus Duecker
  • Publication number: 20040038235
    Abstract: GPRMDA12 polypeptides and polnucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing GPRMDA12 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: May 2, 2003
    Publication date: February 26, 2004
    Inventors: Franz Werner Kluxen, Klaus Duecker
  • Publication number: 20040014706
    Abstract: The present invention relates to the novel finding that inhibition of human CARP protein or of CARP DNA/mRNA may successfully cure heart disorders, especially heart failure in humans. The invention relates, therefore, to pharmaceutical compositions containing substances, preferably of lower molecular weight, which may influence the activity of cardiac CARP. The invention relates, furthermore, to a method of treatment heart failure using CARP inhibitory compounds, to methods for screening these inhibitors and to the use of CARP as diagnostic tool.
    Type: Application
    Filed: August 7, 2003
    Publication date: January 22, 2004
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Claudia Wilm, Marian Braendle, Thomas Eschenhagen, Thomas Eschenhagen, Oliver Zolk
  • Publication number: 20030170808
    Abstract: CARP-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CARP-2 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: August 21, 2002
    Publication date: September 11, 2003
    Inventor: Franz-Werner Kluxen
  • Publication number: 20030138815
    Abstract: PDE7a3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are method for utilizing PDE7a3 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: October 28, 2002
    Publication date: July 24, 2003
    Inventor: Franz-Werner Kluxen
  • Patent number: 6495554
    Abstract: The thienopyrimidines of the formula (I) and their physiologically compatible salts display a phosphodiesterase V inhibiting activity and can be used for treating diseases of the cardiovascular system and for treatment and/or therapy of erectile dysfunction.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: December 17, 2002
    Assignee: Merck Patent Gesellschaft mit beschraenkter Haftung
    Inventors: Rochus Jonas, Pierre Schelling, Franz-Werner Kluxen, Maria Christadler
  • Patent number: 6495557
    Abstract: Thienopyrimidines of the formula I and their physiologically acceptable salts, in which R1, R2 and X have the meanings given in claim 1, inhibit phosphodiesterase V and can be employed for the treatment of illnesses of the cardiovascular system and for the treatment and/or therapy of impaired potency.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: December 17, 2002
    Assignee: Merck Patent Gesellschaft mit beschraenkter Haftung
    Inventors: Rochus Jonas, Pierre Schelling, Franz-Werner Kluxen, Maria Christadler